Seegene, Inc. (KOSDAQ:096530)

Seegene Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	248,484	259,697	190,341	521,348	432,132	308,126
Short-Term Investments	151,975	151,547	205,054	325.75	24.54	1,910
Trading Asset Securities	162,488	111,369	125,447	82,102	41,298	11,229
Cash & Short-Term Investments	562,947	522,613	520,842	603,776	473,454	321,265
Cash Growth	8.90%	0.34%	-13.74%	27.53%	47.37%	386.10%
Accounts Receivable	86,866	87,889	85,553	108,568	338,265	266,323
Other Receivables	3,651	1,957	2,317	1,560	2,130	41,015
Receivables	92,285	91,571	89,154	111,030	340,395	307,339
Inventory	102,699	109,370	137,637	158,195	214,466	139,105
Prepaid Expenses	12,692	13,668	16,836	16,567	12,282	3,907
Other Current Assets	8,934	9,035	5,101	12,938	12,991	11,259
Total Current Assets	779,557	746,257	769,569	902,506	1,053,588	782,874
Property, Plant & Equipment	279,205	282,837	307,444	336,043	317,098	209,093
Long-Term Investments	54,961	54,859	39,065	37,298	41,522	29,673
Goodwill	-	7,234	1,136	1,136	1,136	1,136
Other Intangible Assets	35,159	25,719	26,037	22,680	9,197	3,969
Long-Term Accounts Receivable	479.81	500.41	-	-	12.53	45
Long-Term Deferred Tax Assets	45,148	49,159	52,466	45,210	19,829	25,445
Long-Term Deferred Charges	-	50.63	192.91	621.97	1,125	1,608
Other Long-Term Assets	37,342	33,540	50,241	43,126	43,760	35,520
Total Assets	1,236,996	1,205,279	1,251,452	1,390,778	1,489,719	1,094,575
Accounts Payable	19,494	19,503	25,777	24,369	45,414	87,567
Accrued Expenses	6,007	5,756	4,014	4,533	4,616	5,317
Short-Term Debt	35,000	35,000	35,000	39,500	39,500	37,270
Current Portion of Long-Term Debt	40,792	40,762	40,866	40,994	1,323	703.82
Current Portion of Leases	19,063	19,087	18,694	20,227	15,438	6,589
Current Income Taxes Payable	1,934	904.17	1,267	4,185	97,406	171,563
Other Current Liabilities	48,548	40,428	36,535	36,386	83,081	66,286
Total Current Liabilities	170,839	161,440	162,153	170,194	286,778	375,296
Long-Term Debt	1,430	763.48	1,423	2,168	43,142	44,449
Long-Term Leases	44,976	47,981	45,781	56,296	59,664	14,076
Long-Term Unearned Revenue	345.08	365.18	294.1	-	-	-
Long-Term Deferred Tax Liabilities	482.24	510.52	81.19	435.69	-	58.14
Other Long-Term Liabilities	10,894	10,680	9,956	10,412	7,466	5,919
Total Liabilities	231,387	223,802	221,053	240,499	406,122	448,169
Common Stock	26,113	26,113	26,113	26,113	26,113	13,117
Additional Paid-In Capital	60,711	60,950	62,717	62,717	68,158	81,318
Retained Earnings	1,084,595	1,064,924	1,123,926	1,162,977	1,028,594	564,453
Treasury Stock	-196,288	-196,478	-200,942	-111,066	-40,658	-11,209
Comprehensive Income & Other	27,577	23,117	15,887	7,030	-800.84	-2,362
Total Common Equity	1,002,708	978,626	1,027,701	1,147,771	1,081,406	645,317
Minority Interest	2,901	2,850	2,698	2,508	2,190	1,089
Shareholders' Equity	1,005,609	981,477	1,030,399	1,150,279	1,083,596	646,406
Total Liabilities & Equity	1,236,996	1,205,279	1,251,452	1,390,778	1,489,719	1,094,575
Total Debt	141,262	143,593	141,764	159,185	159,067	103,088
Net Cash (Debt)	421,686	379,019	379,078	444,591	314,387	218,178
Net Cash Growth	14.53%	-0.02%	-14.74%	41.41%	44.10%	327.82%
Net Cash Per Share	9134.89	8211.71	8040.29	8753.94	6069.55	4197.02
Filing Date Shares Outstanding	46.14	46.14	46.04	49.82	51.57	51.98
Total Common Shares Outstanding	46.14	46.14	46.04	49.82	51.57	51.98
Working Capital	608,719	584,817	607,416	732,312	766,810	407,578
Book Value Per Share	21733.55	21209.04	22319.94	23036.65	20971.05	12413.77
Tangible Book Value	967,549	945,674	1,000,527	1,123,955	1,071,072	640,211
Tangible Book Value Per Share	20971.48	20494.88	21729.78	22558.64	20770.65	12315.56
Land	-	110,358	110,312	121,134	114,889	114,887
Buildings	-	12,094	12,094	11,180	13,572	13,572
Machinery	-	262,283	241,440	209,919	153,550	91,524
Construction In Progress	-	15,199	10,761	8,123	16,316	7,714

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.